Orange Book product · Generic (ANDA)
OXYBUTYNIN CHLORIDE
OXYBUTYNIN CHLORIDE
At a glance
Feb 07, 2023
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 07, 2023
3 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
OXYBUTYNIN CHLORIDE
Strength
2.5MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 209025
Product number
002
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of OXYBUTYNIN CHLORIDE
- 2009GELNIQUEBrand (NDA)
NDA 022204 · ABBVIE
- 1998DITROPAN XLBrand (NDA)
NDA 020897 · JANSSEN PHARMS
- —DITROPANBrand (NDA)
NDA 018211 · ORTHO MCNEIL JANSSEN
- —DITROPANBrand (NDA)
NDA 017577 · JANSSEN PHARMS
- 2026OXYBUTYNIN CHLORIDEGeneric (ANDA)
ANDA 075079 · STRIDES PHARMA INTL
- 2022OXYBUTYNIN CHLORIDEGeneric (ANDA)
ANDA 213550 · REGCON HOLDINGS
- 2020OXYBUTYNIN CHLORIDEGeneric (ANDA)
ANDA 208165 · STRIDES PHARMA
- 2020OXYBUTYNIN CHLORIDEGeneric (ANDA)
ANDA 214415 · RUBICON RESEARCH
- 2020OXYBUTYNIN CHLORIDEGeneric (ANDA)
ANDA 212798 · LEADING
- 2019OXYBUTYNIN CHLORIDEGeneric (ANDA)
ANDA 210717 · BIONPHARMA
- 2019OXYBUTYNIN CHLORIDEGeneric (ANDA)
ANDA 210611 · NOVAST LABS
- 2019OXYBUTYNIN CHLORIDEGeneric (ANDA)
ANDA 211682 · AVET LIFESCIENCES
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
